[HTML][HTML] Antibody response to SARS-CoV-2 infection in humans: A systematic review
Background Progress in characterising the humoral immune response to Severe Acute
Respiratory Syndrome 2 (SARS-CoV-2) has been rapid but areas of uncertainty persist. …
Respiratory Syndrome 2 (SARS-CoV-2) has been rapid but areas of uncertainty persist. …
[HTML][HTML] T cell response to SARS-CoV-2 infection in humans: A systematic review
Background Understanding the T cell response to SARS-CoV-2 is critical to vaccine
development, epidemiological surveillance and disease control strategies. This systematic review …
development, epidemiological surveillance and disease control strategies. This systematic review …
[HTML][HTML] Effectiveness of Covid-19 vaccines against the B. 1.617. 2 (Delta) variant
…, CNJ Campbell, G Amirthalingam… - … England Journal of …, 2021 - Mass Medical Soc
Background The B.1.617.2 (delta) variant of the severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (Covid-19), has …
coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (Covid-19), has …
[HTML][HTML] Effectiveness of Covid-19 vaccines against the B. 1.617. 2 (Delta) variant
…, R Myers, CNJ Campbell, G Amirthalingam… - The New England …, 2021 - ncbi.nlm.nih.gov
Background The B. 1.617. 2 (delta) variant of the severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (Covid-19), has …
coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (Covid-19), has …
[HTML][HTML] Pertussis immunisation and control in England and Wales, 1957 to 2012: a historical review
G Amirthalingam, S Gupta, H Campbell - Eurosurveillance, 2013 - eurosurveillance.org
This review summarises the epidemiology and control of pertussis in England and Wales
since the introduction of routine immunisation and considers the implications for future control. …
since the introduction of routine immunisation and considers the implications for future control. …
[HTML][HTML] Duration of protection against mild and severe disease by Covid-19 vaccines
…, CNJ Campbell, G Amirthalingam… - … England Journal of …, 2022 - Mass Medical Soc
Background Vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2),
the virus that causes coronavirus disease 2019 (Covid-19), have been used since …
the virus that causes coronavirus disease 2019 (Covid-19), have been used since …
[HTML][HTML] Covid-19 vaccine effectiveness against the Omicron (B. 1.1. 529) variant
…, G Dabrera, R Myers, G Amirthalingam… - … England Journal of …, 2022 - Mass Medical Soc
Background A rapid increase in coronavirus disease 2019 (Covid-19) cases due to the
omicron (B.1.1.529) variant of severe acute respiratory syndrome coronavirus 2 in highly …
omicron (B.1.1.529) variant of severe acute respiratory syndrome coronavirus 2 in highly …
[HTML][HTML] Risk factors for SARS-CoV-2 among patients in the Oxford Royal College of General Practitioners Research and Surveillance Centre primary care network: a …
…, N Jones, O Akinyemi, G Amirthalingam… - The Lancet Infectious …, 2020 - thelancet.com
Background There are few primary care studies of the COVID-19 pandemic. We aimed to
identify demographic and clinical risk factors for testing positive for severe acute respiratory …
identify demographic and clinical risk factors for testing positive for severe acute respiratory …
Effectiveness of maternal pertussis vaccination in England: an observational study
G Amirthalingam, N Andrews, H Campbell, S Ribeiro… - The Lancet, 2014 - thelancet.com
Background In October, 2012, a pertussis vaccination programme for pregnant women was
introduced in response to an outbreak across England. We aimed to assess the vaccine …
introduced in response to an outbreak across England. We aimed to assess the vaccine …
[HTML][HTML] Robust SARS-CoV-2-specific T cell immunity is maintained at 6 months following primary infection
The immune response to SARS-CoV-2 is critical in controlling disease, but there is concern
that waning immunity may predispose to reinfection. We analyzed the magnitude and …
that waning immunity may predispose to reinfection. We analyzed the magnitude and …